Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients

G.M. Clark; Jennet Harvey; C.K. Osborne; D.C. Allred

Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients

G.M. Clark, Jennet Harvey, C.K. Osborne, D.C. Allred

Research output: Chapter in Book/Conference paper › Other chapter contribution

Original language	English
Title of host publication	Program/Proceedings. American Society of Clinical Oncology. Thirty-Third Annual Meeting. May 17-20, 1997. Denver, CO
Editors	M.C. Perry
Place of Publication	Denver, USA
Publication status	Published - 1997

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Clark, G.M. ; Harvey, Jennet ; Osborne, C.K. et al. / Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients. Program/Proceedings. American Society of Clinical Oncology. Thirty-Third Annual Meeting. May 17-20, 1997. Denver, CO. editor / M.C. Perry. Denver, USA, 1997.

@inbook{5c5184ec0ab84639a62d862b13b7a944,

title = "Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients",

author = "G.M. Clark and Jennet Harvey and C.K. Osborne and D.C. Allred",

year = "1997",

language = "English",

editor = "M.C. Perry",

booktitle = "Program/Proceedings. American Society of Clinical Oncology. Thirty-Third Annual Meeting. May 17-20, 1997. Denver, CO",

}

Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients. / Clark, G.M.; Harvey, Jennet; Osborne, C.K. et al.

Program/Proceedings. American Society of Clinical Oncology. Thirty-Third Annual Meeting. May 17-20, 1997. Denver, CO. ed. / M.C. Perry. Denver, USA, 1997.

Research output: Chapter in Book/Conference paper › Other chapter contribution

TY - CHAP

T1 - Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients

AU - Clark, G.M.

AU - Harvey, Jennet

AU - Osborne, C.K.

AU - Allred, D.C.

PY - 1997

Y1 - 1997

M3 - Other chapter contribution

BT - Program/Proceedings. American Society of Clinical Oncology. Thirty-Third Annual Meeting. May 17-20, 1997. Denver, CO

A2 - Perry, M.C.

CY - Denver, USA

ER -